Arena Pharmaceuticals, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Five

Arena Pharmaceuticals, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Five

Arena Pharmaceuticals, Inc. had Finite-Lived Intangible Asset, Expected Amortization, Year Five of $600.00 thousand as of 2015-12-31, per its 10-K filed 2016-02-29.

Discontinued › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive · last filed 2016-02-29

• 2015-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $600.00K.
• 2014-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $700.00K.